Nephrotic syndrome: vizsgálatok itt: Hollandia

2 trials · From ClinicalTrials.gov, checked 2026. november 15.. Ask the study team whether a trial fits you.

• 2. fázisTaking people
  A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease

  Where

  Amsterdam

  Életkor

  16 év to 75 év

  People

  84 worldwide

  Run by

  Sanofi

  See details and how to joinNCT06500702
• 2. fázisTaking people
  Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases

  Where

  Amsterdam, Nijmegen

  Életkor

  1 év to 17 év

  People

  67 worldwide

  Run by

  Travere Therapeutics, Inc.

  See details and how to joinNCT05003986 · EU 2023-505497-14-00